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To the Editor: The prevalence of tattooing in France was estimated at 14% in 2016 [1, 2]. We 41 
report a national survey among a non-selected sample of the general French population. The 42 
survey was conducted online between April and August 2017 among 5000 individuals ≥15 43 
years selected using a stratified random sampling method from a database including over 44 
1,000,000 Internet users who agreed to participate in various panel surveys. We enquired 45 
about socio-demographics, smoking, skin conditions, tattoo(s) and body-piercings (BP, ear 46 
lobe excluded), motivations for getting tattooed, and cutaneous side-effects. Quality of life 47 
(QoL) was evaluated using the SF-12® health survey.  48 
The prevalence of tattooed people was 16.8% (table 1, 9.9% with 1 tattoo, 6.9% with >1). 49 
Thirty-seven percent of the tattooed individuals had ≥1 BP. Tattooed individuals were more 50 
likely to smoke (44.8% vs. 23.5%, p <0.01), especially those with >1 tattoo (49.3% vs. 51 
41.8%, p=0.03). Women were more likely to have only one tattooed area (51.5% vs. 44.1%, 52 
p=0.008) and men to be heavily tattooed: 13.6% of the them had tattoos on ≥ 5 areas versus 53 
8.4% of the women (p=0.01).  54 
Men had their first tattoo younger than women (24.0±8.9 vs. 26.5 ±10.5, p <0,001). Age at 55 
first tattoo was lower for those who had previously discussed it with their parents (20.4±5.3 vs 56 
26.5±10.4) and 28% of the minors <18 y made their decision alone. Sexuality was a strong 57 
driving factor for men and body reclamation for women. Multivariate analysis showed that 58 
being ≤25 years old at the time of tattooing was associated with testing one’s own stamina 59 
(OR=10; 95% CI: 3.59-28.5; p<0.0001) and body embellishment (OR=1.74; 95% CI:1.23-60 
2.45; p=0.0002). Men were more likely to get at a tattoo for individuality (OR=1.49; 95% CI: 61 
1.08-2.06; p=0.015), for cultural or religious motives (OR=2.37 95% CI:1.25-4.50; p=0.008) 62 
and for sexuality (OR=2.18; 95% CI:1.27-3.73; p = 0.0048). Regaining one’s body was a 63 
strong driving motivation for women, and the lack of a reason was prominent among the 64 
elderly (OR=2.11; 95% CI:1.35-3.29; p<0.0001). Tattooed individuals were more likely to 65 
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report acne, contact eczema and atopic dermatitis (Table 2). Seventeen percent reported past 66 
or present cutaneous problem on one of their tattoos. Irritation was the most common (41%), 67 
followed by infection (25%), delay in healing (24%), and itch (22%). Tattooed men had more 68 
often problems on their tattoos (26%, vs. 11.3%, p < 0.01). Those reporting complications 69 
were also significantly younger (30.2±9.7 vs. 38.5±13.2 y, p<0,0001). Multivariate analyses 70 
are summarized in table 2.  71 
Having tattoo(s) was associated with lower physical and mental QoL, especially for those 72 
with >1 tattoo. Linear regression analysis confirmed that lower physical (p<0.001) and mental 73 
(p=0.0098) scores were significantly associated with having >1 tattoo.   74 
Our results illustrate the overall trend in Western countries. Tattooing is associated with lower 75 
quality of life scores, especially those with several ones. Only 1.9% reported chronic 76 
cutaneous complaints on one of their tattoos [3]. The question whether atopic 77 
dermatitis/contact eczema is more frequently associated with tattoo irritation or if tattooing is 78 
responsible for atopic dermatitis/contact eczema should be investigated. 79 
 80 
 81 
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Tables 92 
Table 1. Characteristics of the study population 93 
 94 
 Total  
n=5000 
Male 
n=2443 
Female  
n=2557 
p-value 
Prevalence by gender 
 840 (16.8) 351 (14.4) 489 (19.1) p<0.001 
Prevalence by age groups (years) 
15-24; n = 802  189 (23.5 ) 72 (18) 117 (29.1) <0.001 
25-34; n = 790  213 (26.9) 92 (23.6) 121 (30.2) <0.001 
35-49; n = 1302  274 ( 21) 115 (17.7) 159 (24.4) <0.001 
50-64; n = 1256  144 (11) 66 (10.9) 78 (11.9) NS  
65-80; n = 850  20 (2.3) 6 (1.5) 14 (3.1) NS  
Tattoos by anatomic distribution 
Back 417 (49.6) 124 (35.4) 293 (59.9) <0.0001 
Shoulder 297 (35.4) 216 (61.7) 81 (16.6) <0.0001 
Forearm 266 (31.7) 117 (33.4) 149 (30.5) NS 
Leg 165 (19.6) 56 (16.0) 109 (22.3) 0.02 
Trunk 136 (16.2) 67 (19.1) 69 (14.1) NS 
Foot 87 (10.4) 20 (5.7) 67 (13.7) 0.0002 
Hand 85 (10.1) 36 (10.3) 49 (10.0) NS 
Intimate 
area/genital 
83 (9.9) 37 (10.6) 46 (9.4) NS 
Neck 59 (7.0) 19 (5.4) 40 (8.1) NS 
Face 53 (6.3) 18 (5.1) 35 (7.2) NS 
Number of anatomic tattooed areas 
1 407 (48.4) 155 (44.1) 252 (51.5) 0.008 
2 199 (23.7) 89 (25.4) 110 (22.5) NS 
3 89 (10.6) 35 (10.0) 54 (11.0) NS 
4 56 (6.7) 24 (6.8) 32 (6.5) NS 
5 24 (2.9) 11 (3.1) 13 (2.7) NS 
6 21 (2.5) 12(3.4) 9 (1.8) NS 
7 6 (0.7) 3 (0.85) 3 (0.6) NS 
8 9 (1.1) 3 (0.85) 6 (1.2) NS 
9 and more 29 (3.4) 19 (5.4) 10 (2.0) 0.035 
Tattoo decision making: alone or discussion with family or friends* 
Alone 486 (57.8) 210 (59.8) 276 (56.4) NS 
Parents 143 (17.0) 68 (19.3) 75 (15.3) NS 
Family 101 (12.0) 39 (11.1) 62 (12.7) NS 
Friends 108 (12.8) 32 (9.1) 76 (15.5) 0.006 
Significant other 92 (10.9) 28 (8.0) 64 (13.1) 0.02 
Self-reported motivations for getting tattooed**  
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Body 
embellishment 
245 (28.5) 93 (25.7) 152 (30.6) NS 
Individuality, 
distinction 
195 (22.7) 96 (26.5) 99 (19.9) 0.02 
Body appropriation 116 (13.5) 34 (9.4) 82 (16.5) 0.003 
Eroticism, sexuality 59 (6.9) 35 (9.7) 24 (4.9) 0.005 
Commitment 48 (5.6) 23 (6.3) 25 (5.0) NS 
Tradition, culture 42 (4.9) 26 (7.2) 16 (3.2) 0.008 
Endurance/stamina 19 (2.2) 6 (1.6) 13 (2.6) NS 
No reason 323 (37.6) 122 (33.7) 201 (40.4) 0.04 
Quality of life SF-
12 
1 tattoo >1 tattoo No tattoos 
(reference) 
p-value 
Physical composite 
score 
51.2±8.2 
- 
- 
49.9±7.9 
51.2±8.3 NS 
0.007 
Mental composite 
score 
41.3±10.1 
- 
- 
41.6±9.1 
44.4±9.5 <0.001 
<0.0001 
NS: not significant 95 
*Total over 100% as respondents could give several answers 96 
**The overall respondent’s number is 859: 19 non-tattooed individuals, who had their tattoo 97 
removed self-reported their motivations for getting tattooed. 98 
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Table 2. Skin conditions and self-reported side effects in tattooed population 126 
 127 
Skin conditions 
 Tattooed 
n=840 
Non-tattooed 
n=4160 
 p-value 
Acne 115 (13.7) 408 (9.8)  0.0008 
Contact eczema  69 (8.2) 185 (4.4)  0.000006 
Psoriasis 45 (5.4) 199 (4.8)  NS 
Atopic 
dermatitis  
41 (4.9) 144 (3.5)  0.046 
Rosacea 29 (3.4) 158 (3.8)  NS 
Vitiligo 5 (0.5) 18 (0.4)  NS 
Adverse skin reaction in tattoo, self-reported 
Past or present 146 (17) -  - 
Solved 92 (10.9) -  - 
Wax and 
waning 
38 (4.5) -  - 
Current 16 (1.9) -  - 
Adverse event 
symptoms 
 1 tattoo 
n=495 
>1 tattoos 
n=345 
 
Delayed healing 35 (4.2) 13 (2.6) 22 (6.4) 0.007 
Irritation 61 (7.3) 19 (3.8) 42 (12.2) 0.000005 
Infection 37 (4.4) 8 (1.6) 29 (8.4) 0.000002 
Itch 32 (3.8) 12 (2.4) 20 (5.8) 0.012 
Multivariate analyses of self-reported tattoo complications*  
Adverse event Significant 
variable 
OR [95% CI]; p-value 
Delay in healing Man gender 
Age < 25 yo 
Contact eczema  
3.72 [1.73:8.00]; 0.0008 
2.29 [1.12:4.70] ; 0.023 
2.71 [1.09:6.76] ; 0.03 
Irritation Man gender 
Multiple tattoos 
Atopic eczema 
Any skin disease 
3.00 [1.68 :5.37] ; 0.0002 
2.95 [1.64 :5.28] ; 0.0003 
4.80 [2.10 :11.0] ; 0.0002 
3.01 [1.70:5.31] ;  0.0001 
Infection Multiple tattoos 
Any skin disease 
4.86 [2.17 :10.9] ; 0.0001 
2.43 [1.21 :4.92] ; 0.013 
Itch Age < 25 yo 2.75 [1.33 :5.68] ; 0.01 
NS: not significant 128 
*analysed variables: age < 25 and > 55 yo, gender, tobacco, acne, contact eczema, atopic 129 
dermatitis, psoriasis and any skin disease 130 
 131 
